| abstract |
The invention relates to a pharmaceutical composition which contains pemafibrate, salts thereof, or solvates thereof and one or more substances selected from the group consisting of metal oxides, dihydric alcohols, esters and the like. of silicic acid compounds, and which has superior storage stability. The present invention relates to a pharmaceutical composition which contains the following components (A) and (B): Component (A) is pemafibrate, salts thereof, or solvates thereof; and component (B) is one or more substances selected from the group consisting of components (B-1) to (B-4), namely, (B-1) metal oxides, (B-2) alcohols dihydric, (B-3) esters and (B-4) silicic acid compounds. In addition, the pharmaceutical composition contains component (A) and component (B) so that the two components do not substantially come into contact with each other. |